Cargando…
Application of QPLEX(TM) biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition
The deposition of beta-amyloid (Aβ) in the brain precedes the onset of symptoms such as cognitive impairment in Alzheimer’s disease (AD); therefore, the early detection of Aβ accumulation is crucial. We previously reported the applicability of the QPLEX(TM) Alz plus assay kit for the prescreening of...
Autores principales: | Lee, Dongjoon, Park, Jong-Chan, Jung, Keum Sim, Kim, Jiyeong, Jang, Ji Sung, Kwon, Sunghoon, Byun, Min Soo, Yi, Dahyun, Byeon, Gihwan, Jung, Gijung, Kim, Yu Kyeong, Lee, Dong Young, Han, Sun-Ho, Mook-Jung, Inhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814000/ https://www.ncbi.nlm.nih.gov/pubmed/35058557 http://dx.doi.org/10.1038/s12276-021-00719-3 |
Ejemplares similares
-
The clinical use of blood-test factors for Alzheimer’s disease: improving the prediction of cerebral amyloid deposition by the QPLEX(TM)Alz plus assay kit
por: Kim, Haeng Jun, et al.
Publicado: (2021) -
Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
por: Park, Jong-Chan, et al.
Publicado: (2021) -
The QPLEX™ Plus Assay Kit for the Early Clinical Diagnosis of Alzheimer’s Disease
por: Na, Hunjong, et al.
Publicado: (2023) -
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer’s disease
por: Park, Jong-Chan, et al.
Publicado: (2023) -
Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints
por: Kim, Jee Wook, et al.
Publicado: (2019)